2025 Annual Meeting | C183 - Neurologic Complications of Novel Anti-neoplastic Therapies Including Immunotherapy

Date Wednesday 04/09/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Yazmin Odia, MD, MS, FAAN

Topic(s) Neuro-oncology

CME Available 2.00 CME credits

Event Timeline
No timeline events available at this time.

Faculty Disclosures
Yazmin Odia, MD, MS, FAAN	Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.